Pharmacy students apply classroom knowledge coast to coast — and around the world
Through internships, USC Mann undergraduates gained firsthand experience in pharmaceutical development, biotechnology, analytics, marketing and community pharmacy.
Can I take a GLP-1 if I have cancer?
A USC endocrinologist discusses whether it is safe for cancer patients and survivors to take medications like Ozempic, Wegovy and Mounjaro.
Laura Abrams installed as dean of the USC Suzanne Dworak-Peck School of Social Work
The youth welfare researcher wants to prepare Trojans for a rapidly changing world, “one that asks us to think outside the box and dream.”
Risks faced by teens online vary by platform, study shows
USC Marshall School of Business researchers say new data could help both families and companies keep kids safer online.
PKD Foundation provides support for kidney disease research by USC’s Zhongwei Li
A two-year, $240,000 grant will back studies developing lab-made tissue to drive progress fighting an incurable genetic condition, autosomal recessive polycystic kidney disease.
Why are employees reluctant to disclose AI use to their bosses?
A USC study explores how organizational mistrust discourages workers from being transparent about their use of artificial intelligence tools.
Technology delegation from Mexico visits USC to explore the university’s AI leadership strategy
The visit from representatives of Grupo Educativo Tecnológico de Monterrey included exploration of possibilities for research collaboration.
Older Americans are taking more medications; more than 1 in 5 at risk for a major drug interaction
Research led by USC’s Dima Qato found the number of patients taking five or more prescription medications at the same time had increased markedly.
USC Gould to convene inaugural Law and AI Summit, attracting leaders who shape artificial intelligence across industries
The February summit will convene executives, judges and general counsel shaping how artificial intelligence is built, governed and defended.
Older adults have strong interest in dementia vaccine, USC survey finds
Nearly 3 in 4 expect they would get a vaccine that would cut high risk in half.









